Literature DB >> 19218702

Interferon gamma production in the course of Mycobacterium tuberculosis infection.

J Winek1, E Rowinska-Zakrzewska, U Demkow, J Szopinski, M Szolkowska, M Filewska, J Jagodzinski, K Roszkowski-Sliz.   

Abstract

It is not clear why some individuals with unknown predisposition develop tuberculosis, while others remain healthy in spite of heavy exposure. Interferon gamma (IFNgamma) is considered to be the key cytokine responsible for resistance to M. tuberculosis infection, as confirmed by increased susceptibility to mycobacterial infections in rare inherited defects in IL-12-IFNgamma axis. The aim of this study was to assess the IFNgamma production by peripheral blood lymphocytes from immunocompetent tuberculosis (TB) patients. The study group included 51 TB patients. In all cases, TB was confirmed by culture. Twenty healthy TB contacts were considered as control group. Commercially available ELISA-based assays were used to measure IFNgamma in the supernatant of whole blood cell cultures after stimulation with PWM (Phytolacca Americana), PHA (phytohemagglutynin), and PPD (purified protein derivative). No difference in IFNgamma secretion between the patients and control group was found when blood cells were stimulated by PWM or PHA. PPD-induced IFNgamma formation was higher in TB patients than in controls. The secretion of IFNgamma after non-specific stimulation varied in different clinical and radiological presentation of tuberculosis and it was lower in most advanced and extensive forms of the disease. It is unclear whether the difference in formation and release of IFNgamma is a primary or secondary phenomenon in the course of the disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19218702

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  5 in total

1.  Host genome polymorphisms and tuberculosis infection: What we have to say?

Authors:  Said Alfin Khalilullah; Harapan Harapan; Nabeeh A Hasan; Wira Winardi; Ichsan Ichsan; Mulyadi Mulyadi
Journal:  Egypt J Chest Dis Tuberc       Date:  2013-12-17

2.  Analysis of immune responses against a wide range of Mycobacterium tuberculosis antigens in patients with active pulmonary tuberculosis.

Authors:  Desta Kassa; Leonie Ran; Wudneh Geberemeskel; Mekashaw Tebeje; Amelewerk Alemu; Alemayehu Selase; Belete Tegbaru; Kees L M C Franken; Annemieke H Friggen; Krista E van Meijgaarden; Tom H M Ottenhoff; Dawit Wolday; Tsehaynesh Messele; Debbie van Baarle
Journal:  Clin Vaccine Immunol       Date:  2012-09-26

3.  Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study.

Authors:  Marlo Möller; Almut Nebel; Paul D van Helden; Stefan Schreiber; Eileen G Hoal
Journal:  BMC Infect Dis       Date:  2010-06-07       Impact factor: 3.090

Review 4.  The CD4+/CD8+ Ratio in Pulmonary Tuberculosis: Systematic and Meta-Analysis Article.

Authors:  Yongmei Yin; Jie Qin; Yaping Dai; Fanwei Zeng; Hao Pei; Jun Wang
Journal:  Iran J Public Health       Date:  2015-02       Impact factor: 1.429

5.  Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis.

Authors:  Mᵃdel Mar Serra-Vidal; Irene Latorre; Kees L C M Franken; Jéssica Díaz; Maria Luiza de Souza-Galvão; Irma Casas; José Maldonado; Cèlia Milà; Jordi Solsona; M Ángeles Jimenez-Fuentes; Neus Altet; Alícia Lacoma; Juan Ruiz-Manzano; Vicente Ausina; Cristina Prat; Tom H M Ottenhoff; José Domínguez
Journal:  Front Microbiol       Date:  2014-10-08       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.